Recursion Pharmaceuticals (NASDAQ: RXRX)
Recursion Pharmaceuticals Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Recursion Pharmaceuticals Company Info
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel medicines. Its Recursion operating system enables advanced machine learning approaches to reveal drug candidates, mechanisms of action, novel chemistry, and potential toxicity, with the eventual goal of decoding biology and advancing new therapeutics that radically improve people's lives. The company was founded by Blake Borgeson, Christopher C. Gibson, and Dean Y. Li on November 5, 2013 and is headquartered in Salt Lake City, UT.
News & Analysis
Should You Buy This Beaten-Down Artificial Intelligence (AI) Stock on the Dip?
Why Recursion Pharmaceuticals Stock Plummeted 24% This Week
Why Recursion Pharmaceuticals Stock Is Plummeting Today
Why Recursion Pharmaceuticals Stock Was Getting Mashed on Monday
This Beaten-Down Artificial Intelligence (AI) Stock Just Got Some Great News: Time to Buy?
Why Recursion Pharmaceuticals Stock Is Skyrocketing Today
Why Biotech Stocks Like Recursion Pharmaceuticals, CRISPR Therapeutics, and Summit Therapeutics Plunged Today
Should Investors Buy These 2 Beaten-Down Artificial Intelligence (AI) Healthcare Stocks?
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.